Search results
Jun 21, 2023 · Dr. Rochelle Walensky surprised many in public health circles last month by announcing her departure after two years and five months — one of the shortest tenures for a CDC director in recent decades. She resigned as the pandemic's national public health emergency was winding down.
Jun 20, 2023 · NEW YORK (AP) — The outgoing head of the Centers for Disease Control and Prevention said Tuesday her reasons for stepping down were complicated, driven in part by a desire to take a break from ...
Jan 6, 2021 · Event date: January 6, 2021, 12 noon. - 1pm Eastern. Moderator: Andrew Kroger, MD, MPH, Medical Officer, Communications and Education Branch, Immunization Services Division, NCIRD, CDC. Speakers and Topics: COVID-19 Vaccines: General Information and Clinical Guidance Update. Kathleen Dooling, MD, MPH, NCIRD, CDC.
Sep 23, 2021 · Strongest evidence in older adults. Vaccine effectiveness of an mRNA primary series remains high in younger age groups. May confer reduced risk of SARS–CoV-2 infection. Waning of vaccine protection via a combination of time since vaccination and delta variant has been observed in most age groups.
- 782KB
- 19
Jan 1, 2020 · Kathleen Dooling M.D. is a Chief Medical Officer for the Centers for Disease Control and Prevention with one video in the C-SPAN Video Library; the first appearance was a 2020 Meeting.
The Centers for Disease Control and Prevention will provide updates about the latest recommendations and clinical considerations for administering COVID-19 boosters, including an update on early safety monitoring for additional COVID-19 vaccine doses.
Jan 27, 2022 · Kathleen Dooling, MD, MPH, Team Lead, Mumps/Varicella/Zoster Team, Division of Viral Diseases, CDC, gave a presentation on the new zoster vaccine ACIP recommendations. There are new ACIP/CDC recommendations for the use of recombinant zoster vaccine (RZV, Shingrix) in immunocompromised adults age 19 and older.
